Brief: ITM And Clovis Oncology Announce Lutetium-177 Clinical Supply Agreement
19/10/2021 13:17
Oct 19 (Reuters) - Clovis Oncology Inc CLVS.O :
* ITM AND CLOVIS ONCOLOGY ANNOUNCE LUTETIUM-177 CLINICAL
SUPPLY
AGREEMENT
* CLOVIS ONCOLOGY - ITM TO SUPPLY ITS MEDICAL RADIOISOTOPE,
NO-CARRIER-ADDED LUTETIUM-177, FOR CLINICAL DEVELOPMENT OF CO'S
FAP-2286
Source text for Eikon: ID:nBw41cZzta
Further company coverage: CLVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber